References Correction
In the published manuscript [1], references 6, 16, 27, 156 and 165 have been replaced with the following references:
-
6.
Nair, M.; Sandhu, S.S.; Sharma, A.K. Cancer molecular markers: A guide to cancer detection and management. In Seminars in Cancer Biology; Academic Press: New York, NY, USA, 2018; Volume 52, pp. 39–55.
-
16.
Jindal, A.; Thadi, A.; Shailubhai, K. Hepatocellular carcinoma: Etiology and current and future drugs. J. Clin. Exp. Hepatol. 2019, 9, 221–232.
-
27.
Leclerc, J.; Flament, C.; Lovecchio, T.; Delattre, L.; Ait Yahya, E.; Baert-Desurmont, S.; Burnichon, N.; Bronner, M.; Cabaret, O.; Lejeune, S.; et al. Diversity of genetic events associated with MLH1 promoter methylation in Lynch syndrome families with heritable constitutional epimutation. Genet. Med. 2018, 20, 1589–1599.
-
156.
Braghini, M.R.; Lo Re, O.; Romito, I.; Fernandez-Barrena, M.G.; Barbaro, B.; Pomella, S.; Rota, R.; Vinciguerra, M.; Avila, M.A.; Alisi, A. Epigenetic remodelling in human hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 2022, 41, 107.
-
165.
Hashemi, M.; Daneii, P.; Zandieh, M.A.; Raesi, R.; Zahmatkesh, N.; Bayat, M.; Abuelrub, A.; Koohpar, Z.K.; Aref, A.R.; Zarrabi, A.; et al. Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response. Non-Coding RNA Res. 2024, 9, 84–104.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Wali A.F., Ansari A.R., Mir P.A., El-Tanani M., Babiker R., Hussain M.S., Uppal J., Zargar A.I., Mir R.H. Epigenetic Alterations in Hepatocellular Carcinoma: Mechanisms, Biomarkers, and Therapeutic Implications. Pharmaceuticals. 2025;18:1281. doi: 10.3390/ph18091281. [DOI] [PMC free article] [PubMed] [Google Scholar]